Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Novartis Ag Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $107 Billion
- Q1 2025
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Novartis Ag stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 1,874 shares of NVS stock, worth $212,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,874
Previous 1,717
9.14%
Holding current value
$212,155
Previous $167,000
24.55%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.34 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.18 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$974 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$799 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$766 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $244B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...